STUDY DESIGN OF ELIXIR, A MULTICENTER EUROPEAN PHASE III CLINICAL TRIAL AIMED TO TEST A GLUCOSE-SPARING PD SOLUTION WHERE GLUCOSE IS MOSTLY REPLACED WITH OSMO-METABOLIC AGENTS

Saved in:
Bibliographic Details
Published inNEPHROLOGY DIALYSIS TRANSPLANTATION Vol. 35; p. 1459
Main Authors Kleophas, W, Bonomini, M, Divino, JC, Reboldi, G, Iacobelli, M, Arduini, A
Format Conference Proceeding
LanguageEnglish
Published 2020
Subjects
Medicin och hälsovetenskap
Online AccessGet full text

Cover

More Information
ISSN:0931-0509